Addex Therapeutics Ltd (ADXN)
7.90
+0.04
(+0.51%)
USD |
NASDAQ |
Dec 20, 16:00
8.16
+0.26
(+3.29%)
After-Hours: 20:00
Addex Therapeutics Profit Margin (Quarterly): -2.84K% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| AC Immune SA | 21.59% |
| CRISPR Therapeutics AG | -- |
| NLS Pharmaceutics Ltd | -- |
| Molecular Partners AG | -2.41K% |
| MoonLake Immunotherapeutics | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 91.08% |
| Return on Assets | 62.62% |
| Return on Invested Capital | 91.08% |
| Operating Margin (Quarterly) | -1.16K% |
| Return on Net Operating Assets | 113.6% |